Skip to content

← All news

Markets

Climb Bio stock surges 17% on positive drug trial results

1 source ·1 article ·Sep 3, 11:31 UTC Climb Bio

Covered by 1 outlet

All coverage · 1 article

Investing.com Stock Market ·Sep 3, 11:31 UTC

Climb Bio stock surges 17% on positive drug trial results